Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?
No Thumbnail Available
Date
2017-10
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Keywords
Rheumatology
Citation
İnanç, N. vd. (2017). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Arthritis & Rheumatology, 69(Supplement 10).